1. Home
  2. ENGNW

ENGNW

enGene Holdings Inc. Warrants

as 04-24-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Founded: N/A Country:
Canada
Canada
Employees: 33 City: SAINT-LAURENT
Market Cap: N/A IPO Year: N/A
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: